Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Alzheimer's Disease

Free Subscription 18.03.2019 5 Alzheimers Dement 1 Biol Psychiatry 3 Brain 6 Curr Alzheimer Res 1 J Alzheimers Dis 5 J Am Geriatr Soc 1 J Neuropsychol 1 J Neurosci 1 Nat Neurosci 1 Nat Rev Neurol 2 Neurobiol Aging 1 Neurol Genet 2 Neurology 1 Neurosci Lett 1 Neuroscience 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Alzheimers Dement

1. WHITWELL JL, Martin P, Graff-Radford J, Machulda MM, et al
   The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.
   Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30010.
   PubMed     Text format     Abstract available
   
   
2. BOS I, Vos S, Verhey F, Scheltens P, et al
   Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
   Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30018.
   PubMed     Text format     Abstract available
   
   
3. JELLINGER KA
   Primary age-related tauopathy (PART) and Alzheimer's disease (AD).
   Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30019.
   PubMed     Text format    
   
   
4. SUGARMAN MA, McKee AC, Stein TD, Tripodis Y, et al
   Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.
   Alzheimers Dement. 2019 Mar 6. pii: S1552-5260(19)30009.
   PubMed     Text format     Abstract available
   
   
5. KOUNTOURAS J, Doulberis M, Polyzos SA, Katsinelos T, et al
   Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia.
   Alzheimers Dement. 2019 Mar 11. pii: S1552-5260(19)30029.
   PubMed     Text format    
   
   

   
   Biol Psychiatry

6. WANG WX
   Micromanaging Memory.
   Biol Psychiatry. 2018;83:390-392.
   PubMed     Text format    
   
   

   
   Brain

7. HERHOLZ K
   Spread of tau deposits: can we trust in vivo findings?
   Brain. 2018;141:10-12.
   PubMed     Text format    
   
   
8. GRATWICKE JP, Foltynie T
   Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson's disease.
   Brain. 2018;141:7-10.
   PubMed     Text format    
   
   
9. ARENAZA-URQUIJO EM, Przybelski SA, Lesnick TL, Graff-Radford J, et al
   The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
   Brain. 2019 Mar 8. pii: 5372751. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Curr Alzheimer Res

10. GAUDREAULT R, Mousseau N
    Mitigating Alzheimer's Disease by Natural Polyphenols : A Review.
    Curr Alzheimer Res. 2019 Mar 14. pii: CAR-EPUB-97358.
    PubMed     Text format     Abstract available
    
    
11. NEPOVIMOV E, Korabecny J, Hepnarova V, Jun D, et al
    N-alkylated Tacrine Derivatives as Potential Agents in Alzheimer's Disease Therapy.
    Curr Alzheimer Res. 2019 Mar 14. pii: CAR-EPUB-97354.
    PubMed     Text format     Abstract available
    
    
12. BROWN EE, Shah P, Pollock BG, Gerretsen P, et al
    Lead (Pb) in Alzheimer's Dementia: A Systematic Review of Human Case-control Studies.
    Curr Alzheimer Res. 2019 Mar 10. pii: CAR-EPUB-97205.
    PubMed     Text format     Abstract available
    
    
13. NAKAMAGOE K, Yamada S, Kawakami R, Koganezawa T, et al
    Abnormal Saccadic Intrusions with Alzheimer's Disease in Darkness.
    Curr Alzheimer Res. 2019 Mar 10. pii: CAR-EPUB-97206.
    PubMed     Text format     Abstract available
    
    
14. FREDERIKSEN KS, Gjerum L, Waldemar G, Hasselbalch SG, et al
    Physical Activity as a Moderator of Alzheimer Pathology: a Systematic Review of Observational Studies.
    Curr Alzheimer Res. 2019 Mar 14. pii: CAR-EPUB-97360.
    PubMed     Text format     Abstract available
    
    
15. MCFALL GP, Bckman L, Dixon RA
    Nuances in Alzheimer's Genetic Risk Reveal Differential Predictions of Non-demented Memory Aging Trajectories: Selective Patterns by APOE Genotype and Sex.
    Curr Alzheimer Res. 2019 Mar 14. pii: CAR-EPUB-97359.
    PubMed     Text format     Abstract available
    
    

    
    J Alzheimers Dis

16. BRANDT J, Buchholz A, Henry-Barron B, Vizthum D, et al
    Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 2. pii: JAD180995. doi: 10.3233/JAD-180995.
    PubMed     Text format     Abstract available
    
    

    
    J Am Geriatr Soc

17. MCDADE E
    Reply to: Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15826.
    PubMed     Text format    
    
    
18. HUANG YM, Shen J, Zhao HL
    Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15830.
    PubMed     Text format    
    
    
19. ZHAO HL, Huang YM
    Reply to: Why Amyloid Is Still a Target for Alzheimer's Disease.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15827.
    PubMed     Text format    
    
    
20. MCDADE E
    Why Amyloid Is Still a Target for Alzheimer disease Clinical Trials.
    J Am Geriatr Soc. 2019 Mar 9. doi: 10.1111/jgs.15829.
    PubMed     Text format    
    
    
21. CHOI S, Kim K, Chang J, Kim SM, et al
    Association of Chronic Periodontitis on Alzheimer's Disease or Vascular Dementia.
    J Am Geriatr Soc. 2019 Mar 15. doi: 10.1111/jgs.15828.
    PubMed     Text format     Abstract available
    
    

    
    J Neuropsychol

22. SONG Y, Wang H
    Motion-induced position mis-localization predicts the severity of Alzheimer's disease.
    J Neuropsychol. 2019 Mar 12. doi: 10.1111/jnp.12181.
    PubMed     Text format     Abstract available
    
    

    
    J Neurosci

23. ALONI E, Oni-Biton E, Tsoory M, Moallem DH, et al
    Synaptopodin deficiency ameliorates symptoms in the 3xTg mouse model of Alzheimer's disease.
    J Neurosci. 2019 Mar 14. pii: JNEUROSCI.2920-18.2019.
    PubMed     Text format     Abstract available
    
    

    
    Nat Neurosci

24. PARK H, Oh J, Shim G, Cho B, et al
    In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease.
    Nat Neurosci. 2019 Mar 11. pii: 10.1038/s41593-019-0352.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Neurol

25. KELSEY R
    New blood-based biomarkers for Alzheimer disease.
    Nat Rev Neurol. 2019 Mar 8. pii: 10.1038/s41582-019-0163.
    PubMed     Text format    
    
    

    
    Neurobiol Aging

26. ESCOTT-PRICE V, Baker E, Shoai M, Leonenko G, et al
    Genetic analysis suggests high misassignment rates in clinical Alzheimer's cases and controls.
    Neurobiol Aging. 2019;77:178-182.
    PubMed     Text format     Abstract available
    
    
27. ZENG CY, Yang TT, Zhou HJ, Zhao Y, et al
    Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer's disease-like pathology and cognitive deficits in mice.
    Neurobiol Aging. 2019;78:18-28.
    PubMed     Text format     Abstract available
    
    

    
    Neurol Genet

28. RAGHAVAN NS, Vardarajan B, Mayeux R
    Genomic variation in educational attainment modifies Alzheimer disease risk.
    Neurol Genet. 2019;5:e310.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

29. CANNON-ALBRIGHT LA, Foster NL, Schliep K, Farnham JM, et al
    Relative risk for Alzheimer disease based on complete family history.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007231.
    PubMed     Text format     Abstract available
    
    
30. VAN HARTEN AC
    Longevity gene KLOTHO may play a role in Alzheimer disease.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007302.
    PubMed     Text format    
    
    

    
    Neurosci Lett

31. JIN L, Lin L, Li GY, Liu S, et al
    Monosodium glutamate exposure during the neonatal period leads to cognitive deficits in adult Sprague-Dawley rats.
    Neurosci Lett. 2018;682:39-44.
    PubMed     Text format     Abstract available
    
    

    
    Neuroscience

32. SANFILIPPO C, Castrogiovanni P, Imbesi R, Tibullo D, et al
    Middle-aged healthy women and Alzheimer's disease patients present an overlapping of brain cell transcriptional profile.
    Neuroscience. 2019 Mar 11. pii: S0306-4522(19)30159.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

33. ORIMAYE SO, Wong JS, Wong CP
    Correction: Deep language space neural network for classifying mild cognitive impairment and Alzheimer-type dementia.
    PLoS One. 2019;14:e0214103.
    PubMed     Text format     Abstract available
    
    
34. ILIEVSKI V, Zuchowska PK, Green SJ, Toth PT, et al
    Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
    PLoS One. 2018;13:e0204941.
    PubMed     Text format     Abstract available
    
    
35. KURIMOTO E, Nakashima M, Kimura H, Suzuki M, et al
    TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.
    PLoS One. 2019;14:e0207969.
    PubMed     Text format     Abstract available
    
    
36. HAFT-JAVAHERIAN M, Fang L, Muse V, Schaffer CB, et al
    Deep convolutional neural networks for segmenting 3D in vivo multiphoton images of vasculature in Alzheimer disease mouse models.
    PLoS One. 2019;14:e0213539.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

37. CATER JH, Kumita JR, Zeineddine Abdallah R, Zhao G, et al
    Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer's-associated amyloid beta peptide.
    Proc Natl Acad Sci U S A. 2019 Mar 8. pii: 1817298116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: